Human megakaryocyte-associated tyrosine kinase (MATK)-related gene variant associated with lung cancers
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 4, 2006
Issued Date -
N/A
app pub date -
Nov 23, 2004
filing date -
Mar 21, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to the nucleic acid of a novel human MATK-related variant (MATKV) and the polypeptides encoded thereby. The invention also provides a process for producing the polypeptide encoded by MATKV. The invention further provides the uses of the nuclei acid of MATKV and the polypeptide encoded thereby in diagnosing the disease associated with the deficiency of human MATK gene, in particular lung cancers, preferably small cell lung cancers.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully